Delivery Order SPE2DE24DA010-SPE2D625F4YZ2

Award Date 7/2/25
Potential Completion Date 7/8/25
Potential Value $69K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The $25,715.85 fixed-price delivery order is for the provision of cardiovascular medical devices and related services, including items such as stents, pacemakers, heart valves, and surgical implants. The contract has an ultimate completion date of May 2, 2025. Abbott Laboratories Inc. is the prime contractor and has established itself as a critical supplier of...
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The contract, valued at $11,750.00, is a fixed-price delivery order with economic price adjustment. The contract is not set aside and was awarded through full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is providing a range of cardiovascular medical devices and technologies to support federal healthcare systems,...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The award has a ceiling value of $21,425.00 and is a fixed-price delivery order contract with economic price adjustment, awarded by the Defense Logistics Agency (DLA), which supports the Department of Defense (DoD) and other federal healthcare systems. The contract covers a range of specialized...
This is a federal contract award to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, by the Defense Logistics Agency (DLA) with a value of $14,850.00. The contract is a delivery order without a set-aside designation, indicating full and open competition. The contract covers the delivery of a range of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. These products are...
This is a $36,320.80 fixed-price delivery order contract awarded to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The contract is for the delivery of cardiovascular medical devices and related services, including items such as stents, pacemakers, heart valves, and surgical implants. The contract supports the medical technology needs of federal healthcare systems, particularly the Department of Veterans Affairs (VA). Abbott Laboratories Inc. has...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order without any set-aside designations, indicating full and open competition. The contract covers the delivery of a range of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. These products...
This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, for the delivery of medical devices, diagnostic equipment, and related services. The contract, valued at $8,541.84, is a fixed-price delivery order with economic price adjustment, awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of cardiovascular medical technologies, such as stents, pacemakers, heart valves, and surgical implants, to support federal healthcare systems,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $44,742.80 fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. The ultimate completion date for this contract is October 25, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $19,000.00 firm fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F4YZ2
    Delivery Order

This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, for the delivery of cardiovascular medical devices and related services. The $68,700.00 fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA), an agency within the Department of Defense, without any set-aside designation, indicating full and open competition.

The contract covers a range of cardiovascular technologies, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. These products support complex medical procedures and improve patient outcomes across federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Health Agency.

Abbott Laboratories Inc. has secured several significant Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Vehicles (IDVs) with federal agencies, demonstrating its strategic importance in federal healthcare procurement. These include a $117,140,796 IDC with the DLA for "procedural packages" covering cardiovascular technologies, and various BPAs under GSA Schedules for medical equipment, supplies, and diagnostic testing solutions.

Generated 10/1/25, 9:53 AM